{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=12", "query": { "intervention": "Control Group Regimen", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 969, "total_pages": 97, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Group+Regimen&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T10:03:25.232Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02742740", "title": "Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Patient Satisfaction", "Patient Compliance", "Guideline Adherence" ], "interventions": [ { "name": "Chemo Buddy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Boston Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2017-09-01", "completion_date": "2018-04-30", "has_results": false, "last_update_posted_date": "2018-06-25", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02742740" }, { "nct_id": "NCT00334958", "title": "Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Rufinamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 356, "start_date": "2006-02-13", "completion_date": "2009-05-20", "has_results": true, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 77, "location_summary": "Mobile, Alabama • Northport, Alabama • Phoenix, Arizona + 61 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Northport", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00334958" }, { "nct_id": "NCT05848713", "title": "AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Community-acquired Pneumonia" ], "interventions": [ { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Manitoba", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4000, "start_date": "2023-10-10", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 6, "location_summary": "Chicago, Illinois • Jefferson, Louisiana • Portland, Maine + 3 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Jefferson", "state": "Louisiana" }, { "city": "Portland", "state": "Maine" }, { "city": "Dearborn", "state": "Michigan" }, { "city": "Camden", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05848713" }, { "nct_id": "NCT07320989", "title": "Impact of Chewing Gum on Bowel Preparation in Patients Undergoing Colonoscopy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colon Cancer Screening" ], "interventions": [ { "name": "Chewing Sugar-Free Gum During Bowel Preparation", "type": "BEHAVIORAL" }, { "name": "Standard Bowel Prep (2L PEG-ELP)", "type": "OTHER" }, { "name": "Standard Bowel Prep", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 100, "start_date": "2026-02-21", "completion_date": "2026-12-30", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 1, "location_summary": "Towson, Maryland", "locations": [ { "city": "Towson", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07320989" }, { "nct_id": "NCT04372589", "title": "Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19", "Pneumonia" ], "interventions": [ { "name": "Heparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Manitoba", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2020-05-20", "completion_date": "2021-05-17", "has_results": false, "last_update_posted_date": "2021-07-27", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 13, "location_summary": "Atlanta, Georgia • Chicago, Illinois • Jefferson, Louisiana + 10 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Jefferson", "state": "Louisiana" }, { "city": "Portland", "state": "Maine" }, { "city": "Dearborn", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04372589" }, { "nct_id": "NCT01951638", "title": "Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "Vericiguat (BAY1021189) (1.25 mg)", "type": "DRUG" }, { "name": "Vericiguat (BAY1021189) (5 mg)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 477, "start_date": "2013-11-06", "completion_date": "2015-09-16", "has_results": true, "last_update_posted_date": "2021-03-16", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 17, "location_summary": "Fountain Valley, California • Fort Lauderdale, Florida • Naples, Florida + 14 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Naples", "state": "Florida" }, { "city": "Macon", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01951638" }, { "nct_id": "NCT07645287", "title": "A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV-1-infection" ], "interventions": [ { "name": "GS-3242 Tablet", "type": "DRUG" }, { "name": "GS-3242 Injection", "type": "DRUG" }, { "name": "Lenacapavir Tablet", "type": "DRUG" }, { "name": "Lenacapavir Injection", "type": "DRUG" }, { "name": "B/F/TAF", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 175, "start_date": "2026-06-15", "completion_date": "2033-04", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 47, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Los Angeles, California + 42 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07645287" }, { "nct_id": "NCT01655407", "title": "Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Thermal Injury", "Deep Partial-Thickness Burn", "Full-Thickness Burn" ], "interventions": [ { "name": "Autologous Engineered Skin Substitute", "type": "DRUG" }, { "name": "Split-Thickness Autograft (AG)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amarantus BioScience Holdings, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 10, "start_date": "2016-09", "completion_date": "2020-07", "has_results": false, "last_update_posted_date": "2016-08-31", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 3, "location_summary": "Pheonix, Arizona • Houston, Texas • Seattle, Washington", "locations": [ { "city": "Pheonix", "state": "Arizona" }, { "city": "Houston", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01655407" }, { "nct_id": "NCT01064414", "title": "An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2", "Renal Insufficiency" ], "interventions": [ { "name": "Canagliflozin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 272, "start_date": "2010-06", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2013-08-14", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 26, "location_summary": "Concord, California • Fountain Valley, California • San Diego, California + 23 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Pembroke Pines", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01064414" }, { "nct_id": "NCT00006734", "title": "Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "adjuvant therapy", "type": "PROCEDURE" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "neoadjuvant therapy", "type": "PROCEDURE" }, { "name": "brachytherapy", "type": "RADIATION" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "0 Years to 50 Years" }, "enrollment_count": 587, "start_date": "2001-05", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2023-08-03", "last_synced_at": "2026-10-22T10:03:25.232Z", "location_count": 212, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 155 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006734" } ] }